Abstract
The status of DNA methylation in the human genome changes during the pathogenesis of common diseases and acts as a predictor of life expectancy. Therefore, it is of interest to investigate the methylation level of regulatory regions of genes responsible for general biological processes that are potentially significant for the development of age-associated diseases. Among them there are genes encoding proteins of DNA repair system, which are characterized by pleiotropic effects. Here, results of the targeted methylation analysis of two regions of the human genome (the promoter of the MLH1 gene and the enhancer near the ATM gene) in different tissues of patients with carotid atherosclerosis are present. Analysis of the methylation profiles of studied genes in various tissues of the same individuals demonstrated marked differences between leukocytes and tissues of the vascular wall. Differences in methylation levels between normal and atherosclerotic tissues of the carotid arteries were revealed only for two studied CpG sites (chr11:108089866 and chr11:108090020, GRCh37/hg19 assembly) in the ATM gene. Based on this, we can assume the involvement of ATM in the development of atherosclerosis. “Overload” of the studied regions with transcription factor binding sites (according to ReMapp2022 data) indicate that the tissue-specific nature of methylation of the regulatory regions of the MLH1 and ATM may be associated with expression levels of these genes in a particular tissue. It has been shown that inter-individual differences in the methylation levels of CpG sites are associated with sufficiently distant nucleotide substitutions.
Similar content being viewed by others
REFERENCES
Feinberg A.P. 2008. Epigenetics at the epicenter of modern medicine. JAMA. 299, 1345–1350. https://doi.org/10.1001/jama.299.11.1345
Paul D.S., Beck S. 2014. Advances in epigenome-wide association studies for common diseases. Trends Mol. Med. 20 (10), 541–543. https://doi.org/10.1016/j.molmed.2014.07.002
Neidhart M. 2015. DNA Methylation and Complex Human Disease. Elsevier. https://doi.org/10.1016/C2013-0-13028-0
Kucher A.N., Nazarenko M.S., Markov A.V., Koroleva I.A., Barbarash O.L. 2017. Variability of methylation profiles of CpG-sites in microRNA genes in leukocytes and vascular tissues of patients with atherosclerosis. Biochemistry (Moscow). 82 (6), 698–706. https://doi.org/10.1134/S0006297917060062
Levy M.A., McConkey H., Kerkhof J., Barat-Houari M., Bargiacchi S., Biamino E., Bralo M.P., Cappuccio G., Ciolfi A., Clarke A., DuPont B.R., Elting M.W., Faivre L., Fee T., Fletcher R.S., Cherik F., Foroutan A., Friez M.J., Gervasini C., Haghshenas S., Hilton B.A., Jenkins Z., Kaur S., Lewis S., Louie R.J., Maitz S., Milani D., Morgan A.T., Oegema R., Ostergaard E., Pallares N.R., Piccione M., Pizzi S., Plomp A.S., Poulton C., Reilly J., Relator R., Rius R., Robertson S., Rooney K., Rousseau J., Santen G.W.E., Santos-Simarro F., Schijns J., Squeo G.M., St John M., Thauvin-Robinet C., Traficante G., van der Sluijs P.J., Vergano S.A., Vos N., Walden K.K., Azmanov D., Balci T., Banka S., Gecz J., Henneman P., Lee J.A., Mannens M.M.A.M., Roscioli T., Siu V., Amor D.J., Baynam G., Bend E.G., Boycott K., Brunetti-Pierri N., Campeau P.M., Christodoulou J., Dyment D., Esber N., Fahrner J.A., Fleming M.D., Genevieve D., Kerrnohan K.D., McNeill A., Menke L.A., Merla G., Prontera P., Rockman-Greenberg C., Schwartz C., Skinner S.A., Stevenson R.E., Vitobello A., Tartaglia M., Alders M., Tedder M.L., Sadikovic B. 2021. Novel diagnostic DNA methylation episignatures expand and refine the epigenetic landscapes of Mendelian disorders. HGG Adv. 3 (1), 100075. https://doi.org/10.1016/j.xhgg.2021.100075
Salameh Y., Bejaoui Y., El Hajj N. 2020. DNA Methylation biomarkers in aging and age-related diseases. Front. Genet. 11, 171. https://doi.org/10.3389/fgene.2020.00171
Yuen R.K., Robinson W.P. 2011. A high capacity of the human placenta for genetic and epigenetic variation: implications for assessing pregnancy outcome. Placenta. 32, S136–S141. https://doi.org/10.1016/j.placenta.2011.01.003
Aavik E., Babu M., Yla-Herttuala S. 2019. DNA methylation processes in atheosclerotic plaque. Atherosclerosis. 281, 168–179. https://doi.org/10.1016/j.atherosclerosis.2018.12.006
Nazarenko M.S., Markov A.V., Koroleva Yu.A., Sleptsov A.A., Kazantsev A.N., Barbarash O.L., Puzyrev V.P. 2017. Identification of differentially methylated genes potentially associated with atherosclerosis in humans. Ross. Kardiol. Zh. 22 (10), 42–48. https://doi.org/10.15829/1560-4071-2017-10-42-48
Koroleva Yu.A., Markov A.V., Goncharova I.A., Sleptsov A.A., Babushkina N.P., Valiakhmetov N.R., Sharysh D.V., Zarubin A.A., Kuznetsov M.S., Kozlov B.N., Nazarenko M.S. 2020. Deoxyribonucleic acid methylation in the enhancer region of the CDKN2A/2B and CDKN2B-AS1 genes in vessels and blood cells in patients with carotid atherosclerosis. Ross. Kardiol. Zh. 25 (10), 32–40. https://doi.org/10.15829/1560-4071-2020-4060
Babushkina N.P., Postrigan A.E., Kucher A.N. 2021. Involvement of variants in the genes encoding BRCA1-associated genome surveillance complex (BASC) in the development of human common diseases. Mol. Biol. (Moscow). 55 (2), 278–296. https://doi.org/10.1134/S0026893321020047
Kar S.P., Quiros P.M., Gu M., Jiang T., Mitchell J., Langdon R., Iyer V., Barcena C., Vijayabaskar M.S., Fabre M.A., Carter P., Petrovski S., Burgess S., Vassiliou G.S. 2022. Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis. Nat. Genet. 54 (8), 1155‒1166. https://doi.org/10.1038/s41588-022-01121-z
Sambrook J., Russel D.W. 2001. Molecular Cloning: A Laboratory Manual. New York: Cold Spring Harbor Lab. Press, 3rd ed.
Hoffman M.M., Ernst J., Wilder S.P., Kundaje A., Harris R.S., Libbrecht M., Giardine B., Ellenbogen P.M., Bilmes J.A., Birney E., Hardison R.C., Dunham I., Kellis M., Noble W.S. 2013. Integrative annotation of chromatin elements from ENCODE data. Nucleic Acids Res. 41 (2), 827–841. https://doi.org/10.1093/nar/gks1284
Fishilevich S., Nudel R., Rappaport N., Hadar R., Plaschkes I., Iny Stein T., Rosen N., Kohn A., Twik M., Safran M., Lancet D., Cohen D. 2017. GeneHancer: genome-wide integration of enhancers and target genes in GeneCards. Database (Oxford). 2017, bax028. https://doi.org/10.1093/database/bax028
Irizarry R.A., Ladd-Acosta C., Wen B., Wu Z., Montano C., Onyango P., Cui H., Gabo K., Rongione M., Webster M., Ji H., Potash J., Sabunciyan S., Feinberg A.P. 2009. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet. 41 (2), 178–186. https://doi.org/10.1038/ng.298
Sandoval J., Heyn H., Moran S., Serra-Musach J., Pujana M.A., Bibikova M., Esteller M. 2011. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics. 6 (6), 692–702. https://doi.org/10.4161/epi.6.6.16196
Masser D.R., Stanford D.R., Freeman W.M. 2015. Targeted DNA methylation analysis by next-generation sequencing. J. Vis. Exp. 96, 52488. https://doi.org/10.3791/52488
Ewels P.A., Peltzer A., Fillinger S., Patel H., Alneberg J., Wilm A., Garcia M.U., Di Tommaso P., Nahnsen S. 2020. The nf-core framework for community-curated bioinformatics pipelines. Nat. Biotechnol. 38 (3), 276–278. https://doi.org/10.1038/s41587-020-0439-x
Pedersen B.S., Eyring K., De S., Yang I.V., Schwartz D.A. 2005. Fast and accurate alignment of long bisulfite-seq reads. arXiv. 1401.1129v2. https://arxiv.org/abs/1401.1129
Krueger F., Andrews S.R. 2011. Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics. 27 (11), 1571–1572. https://doi.org/10.1093/bioinformatics/btr167
Okonechnikov K., Conesa A., Garcia-Alcalde F. 2016. Qualimap 2: advanced multi-sample quality control for high-throughput sequencing data. Bioinformatics. 2 (2), 292–294. https://doi.org/10.1093/bioinformatics/btv566
Daley T., Smith A.D. 2013. Predicting the molecular complexity of sequencing libraries. Nat. Methods. 10 (4), 325–327. https://doi.org/10.1038/nmeth.2375
Ewels P., Magnusson M., Lundin S., Käller M. 2016. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics. 32 (19), 3047–3048. https://doi.org/10.1093/bioinformatics/btw354
Akalin A., Kormaksson M., Li S., Garrett-Bakelman F.E., Figueroa M.E., Melnick A., Mason C.E. 2012. methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles. Genome Biol. 13 (10), R87. https://doi.org/10.1186/gb-2012-13-10-r87
Guo W., Zhu P., Pellegrini M., Zhang M.Q., Wang X., Ni Z. 2018. CGmapTools improves the precision of heterozygous SNV calls and supports allele-specific methylation detection and visualization in bisulfite-sequencing data. Bioinformatics. 34 (3), 381–387. https://doi.org/10.1093/bioinformatics/btx595
Wang K., Li M., Hakonarson H. 2010. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38 (16), e164. https://doi.org/10.1093/nar/gkq603
van der Maaten L.J.P., Hinton G.E. 2008. Visualizing data using t-SNE. J. Mach. Learn. Res. 9, 2579–2605.
Barrett J.C., Fry B., Maller J., Daly M.J. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 21 (2), 263–265. https://doi.org/10.1093/bioinformatics/bth457
Nettersheim F.S., Picard F.S.R., Hoyer F.F., Winkels H. 2022. Immunotherapeutic strategies in cancer and atherosclerosis-two sides of the same coin. Front. Cardiovasc. Med. 8, 812702. https://doi.org/10.3389/fcvm.2021.812702
Fasehee H., Fakhraee M., Davoudi S., Vali H., Faghihi S. 2019. Cancer biomarkers in atherosclerotic plaque: evidenced from structural and proteomic analyses. Biochem. Biophys. Res. Commun. 509 (3), 687–693. https://doi.org/10.1016/j.bbrc.2018.12.160
Byrd P.J., Cooper P.R., Stankovic T., Kullar H.S., Watts G.D., Robinson P.J., Taylor M.R. 1996. A gene transcribed from the bidirectional ATM promoter coding for a serine rich protein: amino acid sequence, structure and expression studies. Hum. Mol. Genet. 5 (11), 1785–1791. https://doi.org/10.1093/hmg/5.11.1785
Medina R., van der Deen M., Miele-Chamberland A., Xie R.L., van Wijnen A.J., Stein J.L., Stein G.S. 2007. The HiNF-P/p220NPAT cell cycle signaling pathway controls nonhistone target genes. Cancer Res. 67 (21), 10334–10342. https://doi.org/10.1158/0008-5472.CAN-07-1560
Lesurf R., Cotto K.C., Wang G., Griffith M., Kasaian K., Jones S.J., Montgomery S.B., Griffith O.L.; Open Regulatory Annotation Consortium. 2016. ORegAnno 3.0: a community-driven resource for curated regulatory annotation. Nucleic Acids Res. 44 (D1), D126‒D132. https://doi.org/10.1093/nar/gkv1203
Floyd S.R., Pacold M.E., Huang Q., Clarke S.M., Lam F.C., Cannell I.G., Bryson B.D., Rameseder J., Lee M.J., Blake E.J., Fydrych A., Ho R., Greenberger B.A., Chen G.C., Maffa A., Del Rosario A.M., Root D.E., Carpenter A.E., Hahn W.C., Sabatini D.M., Chen C.C., White F.M., Bradner J.E., Yaffe M.B. 2013. The bromodomain protein Brd4 insulates chromatin from DNA damage signalling. Nature. 498 (7453), 246–250. https://doi.org/10.1038/nature12147
Muhar M., Ebert A., Neumann T., Umkehrer C., Jude J., Wieshofer C., Rescheneder P., Lipp J.J., Herzog V.A., Reichholf B., Cisneros D.A., Hoffmann T., Schlapansky M.F., Bhat P., von Haeseler A., Köcher T., Obenauf A.C., Popow J., Ameres S.L., Zuber J. 2018. SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis. Science. 360 (6390), 800–805. https://doi.org/10.1126/science.aao2793
Kumar R., Manning J., Spendlove H.E., Kremmidiotis G., McKirdy R., Lee J., Millband D.N., Cheney K.M., Stampfer M.R., Dwivedi P.P., Morris H.A., Callen D.F. 2006. ZNF652, a novel zinc finger protein, interacts with the putative breast tumor suppressor CBFA2T3 to repress transcription. Mol. Cancer Res. 4 (9), 655–665. https://doi.org/10.1158/1541-7786.MCR-05-0249
Pilarowski G.O., Vernon H.J., Applegate C.D., Boukas L., Cho M.T., Gurnett C.A., Benke P.J., Beaver E., Heeley J.M., Medne L., Krantz I.D., Azage M., Niyazov D., Henderson L.B., Wentzensen I.M., Baskin B., Sacoto M.J.G., Bowman G.D., Bjornsson HT. 2018. Missense variants in the chromatin remodeler CHD1 are associated with neurodevelopmental disability. J. Med. Genet. 55 (8), 561–566. https://doi.org/10.1136/jmedgenet-2017-104759
Hossain M.B., Vahter M., Concha G., Broberg K. 2012. Environmental arsenic exposure and DNA methylation of the tumor suppressor gene p16 and the DNA repair gene MLH1: effect of arsenic metabolism and genotype. Metallomics. 4 (11), 1167–1175. https://doi.org/10.1039/c2mt20120h
Ghosh M., Oner D., Poels K., Tabish A.M., Vlaanderen J., Pronk A., Kuijpers E., Lan Q., Vermeulen R., Bekaert B., Hoet P.H., Godderis L. 2017. Changes in DNA methylation induced by multi-walled carbon nanotube exposure in the workplace. Nanotoxicology. 11 (9–10), 1195–1210. https://doi.org/10.1080/17435390.2017.1406169
Sanchez H., Hossain M.B., Lera L., Hirsch S., Albala C., Uauy R., Broberg K., Ronco A.M. 2017. High levels of circulating folate concentrations are associated with DNA methylation of tumor suppressor and repair genes p16, MLH1, and MGMT in elderly Chileans. Clin. Epigenetics. 9, 74. https://doi.org/10.1186/s13148-017-0374-y
Remely M., Ferk F., Sterneder Sюю, Setayesh T., Kepcija T., Roth S., Noorizadeh R., Greunz M., Rebhan I., Wagner K.H., Knasmüller S., Haslberger A. 2017. Vitamin E modifies high-fat diet-induced increase of DNA strand breaks, and changes in expression and DNA methylation of Dnmt1 and MLH1 in C57BL/6J male mice. Nutrients. 9 (6), 607. https://doi.org/10.3390/nu9060607
Bhattacharjee P., Sanyal T., Bhattacharjee S., Bhattacharjee P. 2018. Epigenetic alteration of mismatch repair genes in the population chronically exposed to arsenic in West Bengal, India. Environ. Res. 163, 289–296. https://doi.org/10.1016/j.envres.2018.01.002
Zappe K., Pointner A., Switzeny O.J., Magnet U., Tomeva E., Heller J., Mare G., Wagner K.H., Knasmueller S., Haslberger A.G. 2018. Counteraction of oxidative stress by vitamin E affects epigenetic regulation by increasing global methylation and gene expression of MLH1 and DNMT1 dose dependently in Caco-2 cells. Oxid. Med. Cell Longev. 3734250. https://doi.org/10.1155/2018/3734250
Mohammad G., Radhakrishnan R., Kowluru R.A. 2019. Epigenetic modifications compromise mitochondrial DNA quality control in the development of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 60 (12), 3943–3951. https://doi.org/10.1167/iovs.19-27602
Mulder R.H., Neumann A., Cecil C.A.M., Walton E., Houtepen L.C., Simpkin A.J., Rijlaarsdam J., Heijmans B.T., Gaunt T.R., Felix J.F., Jaddoe V.W.V., Bakermans-Kranenburg M.J., Tiemeier H., Relton C.L., van IJzendoorn M.H., Suderman M. 2021. Epigenome-wide change and variation in DNA methylation in childhood: trajectories from birth to late adolescence. Hum. Mol. Genet. 30 (1), 119–134. https://doi.org/10.1093/hmg/ddaa280
Feinberg A.P., Irizarry R.A. 2010. Evolution in health and medicine Sackler colloquium: stochastic epigenetic variation as a driving force of development, evolutionary adaptation, and disease. Proc. Natl. Acad. Sci. USA. 107 (1), 1757–1764. https://doi.org/10.1073/pnas.0906183107
Grundberg E., Meduri E., Sandling J.K., Hedman A.K., Keildson S., Buil A., Busche S., Yuan W., Nisbet J., Sekowska M., Wilk A., Barrett A., Small K.S., Ge B., Caron M., Shin S.Y.; Multiple Tissue Human Expression Resource Consortium; Lathrop M., Dermitzakis E.T., McCarthy M.I., Spector T.D., Bell J.T., Deloukas P. 2013. Global analysis of DNA methylation variation in adipose tissue from twins reveals links to disease-associated variants in distal regulatory elements. Am. J. Hum. Genet. 93 (5), 876–890. https://doi.org/10.1016/j.ajhg.2013.10.004
Ahsan M., Ek W.E., Rask-Andersen M., Karlsson T., Lind-Thomsen A., Enroth S., Gyllensten U., Johansson A. 2017. The relative contribution of DNA methylation and genetic variants on protein biomarkers for human diseases. PLoS Genet. 13 (9), 1007005. https://doi.org/10.1371/journal.pgen.1007005
Zhou D., Li Z., Yu D., Wan L., Zhu Y., Lai M., Zhang D. 2015. Polymorphisms involving gain or loss of CpG sites are significantly enriched in trait-associated SNPs. Oncotarget. 6 (37), 39995–40004. https://doi.org/10.18632/oncotarget.5650
Gong J., Wan H., Mei S., Ruan H., Zhang Z., Liu C., Guo A.Y., Diao L., Miao X., Han L. 2019. Pancan-meQTL: a database to systematically evaluate the effects of genetic variants on methylation in human cancer. Nucleic Acids Res. 47 (D1), D1066–D1072. https://doi.org/10.1093/nar/gky814
Babushkina N.P., Kucher A.N. 2023. Regulatory potential of SNP markers in genes of DNA repair systems. Mol. Biol. (Moscow). 57 (1), 19–38.
Zaina S., Heyn H., Carmona F.J., Varol N., Sayols S., Condom E., Ramírez-Ruz J., Gomez A., Gonçalves I., Moran S., Esteller M. 2014. DNA methylation map of human atherosclerosis. Circ. Cardiovasc. Genet. 7 (5), 692–700. https://doi.org/10.1161/CIRCGENETICS.113.000441
Li J., Zhang X., Yang M., Yang H., Xu N., Fan X., Liu G., Jiang X., Fan J., Zhang L., Zhang H., Zhou Y., Li R., Gao S., Jin J., Jin Z., Zheng J., Tu Q., Ren J. 2021. DNA methylome profiling reveals epigenetic regulation of lipoprotein-associated phospholipase A2 in human vulnerable atherosclerotic plaque. Clin. Epigenetics. 13 (1), 161. https://doi.org/10.1186/s13148-021-01152-z
Istas G., Declerck K., Pudenz M., Szic K.S.V., Lendinez-Tortajada V., Leon-Latre M., Heyninck K., Haegeman G., Casasnovas J.A., Tellez-Plaza M., Gerhauser C., Heiss C., Rodriguez-Mateos A., Berghe W.V. 2017. Identification of differentially methylated BRCA1 and CRISP2 DNA regions as blood surrogate markers for cardiovascular disease. Sci. Rep. 7 (1), 5120. https://doi.org/10.1038/s41598-017-03434-0
ACKNOWLEDGMENTS
We are grateful to Cand. Sci. (Med.) A.V. Markov for help in experiment planning and preparation.
The study was performed using equipment of the Medical Genomics Collective Access Center (Tomsk National Research Medical Center) and the Biobank of the North Eurasian Population (Research Institute of Medical Genetics, Tomsk National Research Medical Center).
Funding
This work was supported by the Ministry of Science and Higher Education (project no. 122020300041-7).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interests. The authors declare that they have no conflict of interest.
Statement of compliance with standards of research involving humans as subjects. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants involved in the study. The study has been approved by the Ethics Committee at the Institute of Medical Genetics (protocol no. 10 dated February 15, 2021).
Additional information
Translated by T. Tkacheva
Supplementary Information
Rights and permissions
About this article
Cite this article
Babushkina, N.P., Zarubin, A.A., Koroleva, I.A. et al. Methylation of Regulatory Regions of DNA Repair Genes in Carotid Atherosclerosis. Mol Biol 57, 637–652 (2023). https://doi.org/10.1134/S0026893323040027
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0026893323040027